Nick Giannasi is an experienced healthcare technology executive with over 20 years of experience supporting healthcare and life sciences businesses through data, artificial intelligence, product development, partnerships, and M&A.

Most recently, Mr. Giannasi served as the Chief Product Officer for Ciox and Head of Demand Side Product for Datavant, a healthcare technology company that connects the world’s data to improve patient outcomes. Prior to this, he served as EVP, Chief AI Officer, Chief Data Officer and SVP of Data Sciences and Product Management at Change Healthcare, where he defined and led the execution of a strategy for applied artificial intelligence and also led the company’s enterprise-wide data quality and life-cycle management. Before that, he served as Vice President of Life Sciences Product Strategy at Oracle.

Earlier in his career, Mr. Giannasi had leadership roles at Amersham, Double Twist, and GE Healthcare. He also co-founded the biotech company Phenocure LTD.

Mr. Giannasi currently serves as a board member at Aspirion, and as Executive Chairman of Infinia ML, an Aspirion company, both Linden portfolio companies. He also serves as a board member at Motiva.ai and is a senior advisor to Datavant.

Mr. Giannasi holds a Bachelor of Science, with First Class Honors, in Zoology and Biochemistry from the University of Reading, earned his Ph.D. in Molecular, Behavioral, and Morphological Evolution from the University of Wales, and performed post-doctoral research under a Leverhulme Fellowship with Novartis.